Trending: Philips in Final Agreement With DOJ, FDA on Ventilators
1411 ET -- Philips is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The company reached a final agreement with the U.S. Justice Department and Food and Drug Administration on a settlement related to Respironics ventilators. According to the DOJ, Philips is required to stop manufacturing most sleep and respiratory devices at three Pennsylvania facilities until it takes specific measures. The company discussed its progress, including working with the FDA, and said "we now have a clear path forward to gradually restore the business, serving patients around the world." Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)
(END) Dow Jones Newswires
April 10, 2024 14:27 ET (18:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?